Study: Common antibiotic kills drug-resistant bacteria
Stephen FellerSAN DIEGO, June 10 (UPI) -- The common antibiotic azithromycin, sold as Zithromax Z-Pak, was found to kill multidrug-resistant bacteria in lab tests more closely mimicking the human body. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 10, 2015 Category: Consumer Health News Source Type: news

Common antibiotic may be the answer to many multidrug-resistant bacterial infections
The common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively — when tested under conditions that closely resemble the human body and its natural antimicrobial factors. The researchers believe the finding could prompt an immediate review of the current standard of care for patients with certain so-called “superbug” infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2015 Category: Science Source Type: news

Common antibiotic may be the answer to many multidrug-resistant bacterial infections
(University of California - San Diego) Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that the common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively -- when tested under conditions that closely resemble the human body and its natural antimicrobial factors. The researchers believe the finding, published June 10 by EBioMedicine, could prompt an immediate review of the current standard of care for patients with certain so-called 'superbug' infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2015 Category: Infectious Diseases Source Type: news

CDC Issues Advisory About Multi-Drug Resistant Shigellosis (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The CDC is increasingly seeing shigellosis that's resistant to ciprofloxacin or azithromycin, as well as other antimicrobials, the agency warned in a health alert … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 8, 2015 Category: Primary Care Source Type: news

Growing Concern Over Drug-Resistant Shigella in USGrowing Concern Over Drug-Resistant Shigella in US
Recent outbreaks of Shigellosis in the United States that are resistant to ciprofloxacin, azithromycin, and other antibiotics prompts a Health Alert Network advisory from federal health officials. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 6, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men — Chicago and Metropolitan Minneapolis-St. Paul, 2014
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 5, 2015 Category: American Health Source Type: news

Azithromycin Unlikely to Be Effective for Shigellosis in Men Who Have Sex With Men (FREE)
By Cara Adler Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS All tested Shigella isolates from two recent outbreaks among men who have sex with men showed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 5, 2015 Category: Primary Care Source Type: news

Azithromycin vs Doxycycline in Meibomian Gland DysfunctionAzithromycin vs Doxycycline in Meibomian Gland Dysfunction
In a new head-to-head comparison of the two antibiotics for meibomian gland dysfunction, azithromycin showed to be the overall better treatment choice. The British Journal of Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2015 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Case Western Reserve global health expert urges action to eradicate yaws, tropical disease
(Case Western Reserve University) Half a century ago, a concentrated global effort nearly wiped a disfiguring tropical disease from the face of the earth. Now, says Case Western Reserve's James W. Kazura, M.D., it's time to complete the work. In a perspective column in the Feb.19 New England Journal of Medicine, Kazura responded to a research article that demonstrated positive results from a single oral dose of azithromycin. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 19, 2015 Category: Infectious Diseases Source Type: news

Doxycycline May Be Better Choice for Rectal Chlamydia InfectionDoxycycline May Be Better Choice for Rectal Chlamydia Infection
Seven days of doxycycline may be better than a single dose of azithromycin for treating rectal chlamydia infection, according to a systematic review and meta-analysis of eight observational studies. Reuters Health Information (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - February 20, 2015 Category: OBGYN Tags: Infectious Diseases News Source Type: news

Azithromycin Linked to Pyloric Stenosis Risk in Young Infants Azithromycin Linked to Pyloric Stenosis Risk in Young Infants
Oral azithromycin or erythromycin use may increase risk for infantile hypertrophic pyloric stenosis, particularly with exposure in the first 2 weeks of life, according to a retrospective cohort study. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2015 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Improving antibiotics to treat staph infections
New information about how antibiotics like azithromycin stop staph infections has been uncovered, including why staph sometimes becomes resistant to drugs. Staphylococcus aureus (familiar to many as the common and sometimes difficult to treat staph infection) is a strain of bacteria that frequently has become resistant to antibiotics, a development that has been challenging for doctors and dangerous for patients with severe infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 23, 2015 Category: Science Source Type: news

SLU scientist aims to improve antibiotics to treat staph infections
(Saint Louis University) Saint Louis University's Mee-Ngan F. Yap, Ph.D., discovered new information about how antibiotics like azithromycin stop staph infections, and why staph sometimes becomes resistant to drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2015 Category: Global & Universal Source Type: news

Azithromycin Therapy May Quell Orofacial GranulomatosisAzithromycin Therapy May Quell Orofacial Granulomatosis
Weekly azithromycin pulse therapy appears to be a swift and effective means of treating orofacial granulomatosis, according to a case series from India. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 18, 2014 Category: Dermatology Tags: Dermatology News Source Type: news

Strep Throat: Where Does Azithromycin Fit?Strep Throat: Where Does Azithromycin Fit?
Are you overutilizing azithromycin for strep throat? Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 18, 2014 Category: Drugs & Pharmacology Tags: Pediatrics Ask the Expert Source Type: news